Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Non-cash Items (2020 - 2024)

Historic Non-cash Items for Relay Therapeutics (RLAY) over the last 5 years, with Q4 2024 value amounting to $7.9 million.

  • Relay Therapeutics' Non-cash Items fell 5844.44% to $7.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $7.9 million, marking a year-over-year decrease of 5844.44%. This contributed to the annual value of $7.9 million for FY2024, which is 5844.44% down from last year.
  • As of Q4 2024, Relay Therapeutics' Non-cash Items stood at $7.9 million, which was down 5844.44% from $18.9 million recorded in Q4 2023.
  • In the past 5 years, Relay Therapeutics' Non-cash Items ranged from a high of $196.6 million in Q4 2020 and a low of $7.9 million during Q4 2024
  • For the 5-year period, Relay Therapeutics' Non-cash Items averaged around $73.8 million, with its median value being $34.6 million (2022).
  • Per our database at Business Quant, Relay Therapeutics' Non-cash Items crashed by 4353.93% in 2021 and then tumbled by 6879.24% in 2022.
  • Relay Therapeutics' Non-cash Items (Quarter) stood at $196.6 million in 2020, then plummeted by 43.54% to $111.0 million in 2021, then crashed by 68.79% to $34.6 million in 2022, then plummeted by 45.43% to $18.9 million in 2023, then plummeted by 58.44% to $7.9 million in 2024.
  • Its Non-cash Items was $7.9 million in Q4 2024, compared to $18.9 million in Q4 2023 and $34.6 million in Q4 2022.